COR758, a negative allosteric modulator of GABAB receptors

Neuropharmacology. 2021 May 15:189:108537. doi: 10.1016/j.neuropharm.2021.108537. Epub 2021 Mar 30.

Abstract

Allosteric modulators of G protein coupled receptors (GPCRs), including GABABRs (GABABRs), are promising therapeutic candidates. While several positive allosteric modulators (PAM) of GABABRs have been characterized, only recently the first negative allosteric modulator (NAM) has been described. In the present study, we report the characterization of COR758, which acts as GABABR NAM in rat cortical membranes and CHO cells stably expressing GABABRs (CHO-GABAB). COR758 failed to displace the antagonist [3H]CGP54626 from the orthosteric binding site of GABABRs showing that it acts through an allosteric binding site. Docking studies revealed a possible new allosteric binding site for COR758 in the intrahelical pocket of the GABAB1 monomer. COR758 inhibited basal and GABABR-stimulated O-(3-[35Sthio)-triphosphate ([35S]GTPγS) binding in brain membranes and blocked the enhancement of GABABR-stimulated [35S]GTPγS binding by the PAM GS39783. Bioluminescent resonance energy transfer (BRET) measurements in CHO-GABAB cells showed that COR758 inhibited G protein activation by GABA and altered GABABR subunit rearrangements. Additionally, the compound altered GABABR-mediated signaling such as baclofen-induced inhibition of cAMP production in transfected HEK293 cells, agonist-induced Ca2+ mobilization as well as baclofen and the ago-PAM CGP7930 induced phosphorylation of extracellular signal-regulated kinases (ERK1/2) in CHO-GABAB cells. COR758 also prevented baclofen-induced outward currents recorded from rat dopamine neurons, substantiating its property as a NAM for GABABRs. Altogether, these data indicate that COR758 inhibits G protein signaling by GABABRs, likely by interacting with an allosteric binding-site. Therefore, COR758 might serve as a scaffold to develop additional NAMs for therapeutic intervention.

Keywords: Allosteric modulators; Bioluminescence resonance energy transfer (BRET); GABA(B) receptors; GTPγS binding; Negative allosteric modulator (NAM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation / drug effects
  • Allosteric Regulation / physiology
  • Animals
  • Bioluminescence Resonance Energy Transfer Techniques / methods
  • CHO Cells
  • Cricetulus
  • Dose-Response Relationship, Drug
  • GABA Modulators / chemistry*
  • GABA Modulators / pharmacology*
  • GABA-B Receptor Agonists / chemistry
  • GABA-B Receptor Agonists / pharmacology
  • GABA-B Receptor Antagonists / chemistry*
  • GABA-B Receptor Antagonists / pharmacology*
  • Humans
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-B / physiology*
  • gamma-Aminobutyric Acid / chemistry
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • GABA Modulators
  • GABA-B Receptor Agonists
  • GABA-B Receptor Antagonists
  • Receptors, GABA-B
  • gamma-Aminobutyric Acid